Put the Script Pad Down: FDA’s New Drug Approvals Pose Significant Risks
For every 100 new drugs introduced in the market, there have been 34 withdrawals or new black box warnings in the past 25 years. Since 1992, FDA sped up the pace and approval process for pharmaceutical companies willing to pay a fee. Approval time was cut in half, but with it came a significant number of safety withdrawals and warnings. This study, released today in Health Affairs, shows the expeditious process has placed millions of Americans at risk, essentially making them unwitting members of safety trials after the drug was approved.